Table E5.
Multivariate∗ analysis for the association between steroids use and all-cause mortality within 90 d following PCR test date among adult asthmatic patients with positive PCR test result for SARS-CoV-2, using different specifications of steroid use (n = 8242)
| Variable | Adjusted∗ HR (95% CI) | P value |
|---|---|---|
| Steroids use in the previous year | ||
| None | Reference | |
| Yes | 1.16 (0.81-1.64) | .418 |
| Steroids use in the previous year | ||
| None | Reference | |
| Recent (≤120 d) | 1.40 (0.92-2.15) | .120 |
| Former (120-365 d) | 0.93 (0.57-1.51) | .769 |
| Chronic steroids treatment (≥6 prescriptions in the previous year) | ||
| None | Reference | |
| Yes | 2.00 (1.18-3.40) | .010 |
| Steroids use in the previous year (no. of filled prescriptions) | ||
| None | Reference | |
| 1 prescription | 0.91 (0.53-1.56) | .733 |
| 2 prescriptions | 0.86 (0.42-1.78) | .694 |
| ≥3 prescriptions | 1.64 (1.04-2.59) | .032 |
∗
Adjusted for age, sex, ethnicity, diabetes, hypertension, ischemic heart disease, obesity, smoking, and biologics use.